The RISMUS Cohort Study: Risk Among Music Students.
Launched by QUEEN MARGARET UNIVERSITY · Aug 4, 2018
Trial Information
Current as of May 28, 2025
Unknown status
Keywords
ClinConnect Summary
Professional musicians are exposed to chronic high volume of continuous and repeated physical movements, sometimes in challenging and ergonomically unfavourable anatomical body positions, in order to acquire and improve technical playing skills. As a consequence, musicians are vulnerable to developing adverse playing-related musculoskeletal disorders (PRMDs) that may affect the manner in which and the extent to which music can be practised and performed.
In order to find out effective solutions for PRMDs and to develop future preventive measures, it is fundamental to firstly identify the m...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All pre-college and university-level students from music academies, with a classical instrument as main subject.
- Exclusion Criteria:
- • Music students without a classical instrument as main subject (composers and conductors)
- • Positive history for neurological, rheumatic, psychological disorders or emotional distress, as well as surgery of the upper limbs and/or the spine in the last 12 months.
About Queen Margaret University
Queen Margaret University (QMU) is a renowned institution dedicated to advancing health and social care through innovative research and academic excellence. With a strong emphasis on interdisciplinary collaboration, QMU engages in clinical trials that aim to enhance patient outcomes and inform evidence-based practices. The university’s commitment to addressing real-world health challenges is reflected in its partnerships with healthcare providers and stakeholders, ensuring that research findings translate effectively into practice. Through its robust ethical standards and focus on participant welfare, QMU is poised to contribute significantly to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Cinzia Cruder, MA
Principal Investigator
Queen Margaret University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials